Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Acquisitions & Divestments (2019 - 2025)

Outset Medical (OM) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $37.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 67.6% to $37.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $125.1 million, a 52.16% decrease, with the full-year FY2025 number at $125.1 million, down 52.16% from a year prior.
  • Change in Acquisitions & Divestments was $37.0 million for Q4 2025 at Outset Medical, down from $43.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $114.3 million in Q4 2024 to a low of $4.4 million in Q3 2021.
  • A 5-year average of $46.7 million and a median of $42.9 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 1229.55% in 2022, then crashed 67.6% in 2025.
  • Outset Medical's Change in Acquisitions & Divestments stood at $14.7 million in 2021, then soared by 191.18% to $42.9 million in 2022, then skyrocketed by 75.99% to $75.5 million in 2023, then surged by 51.41% to $114.3 million in 2024, then plummeted by 67.6% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Change in Acquisitions & Divestments are $37.0 million (Q4 2025), $43.2 million (Q3 2025), and $26.5 million (Q2 2025).